• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种靶向两种不同CD73表位的抗体鸡尾酒可增强酶抑制作用并控制肿瘤。

An antibody cocktail targeting two different CD73 epitopes enhances enzyme inhibition and tumor control.

作者信息

Xu Jin-Gen, Chen Shi, He Yang, Zhu Xi, Wang Yanting, Ye Zhifeng, Zhou Jin Chuan, Wu Xuanhui, Zhang Lei, Ren Xiaochen, Jia Huifeng, Yu Haijia, Wei Xiaoyue, Feng Yujie, Chen Xiaofang, Cui Xiaopei, Pan Xianfei, Wang Shaojie, Xia Simin, Shang Hongjie, Pu Yueqing, Xu Wei, Li Haidong, Chen Qian, Chen Zeyu, Wang Manfu, Yan Xiaodong, Shi Hui, Li Mingwei, Xia Yisui, Bellelli Roberto, Dong Shunli, He Jun, Huang Jun, Cai Chen-Leng, Zhu Xiangyang, Zhan Yifan, Wan Li

机构信息

Key Laboratory of Immune Response and Immunotherapy, Guangzhou Institutes of Biomedicine and Health (GIBH), Chinese Academy of Scienes, Guangzhou, China.

Drug Discovery, Shanghai Huaota Biopharmaceutical Co. Ltd., Shanghai, China.

出版信息

Nat Commun. 2024 Dec 30;15(1):10872. doi: 10.1038/s41467-024-55207-9.

DOI:10.1038/s41467-024-55207-9
PMID:39738003
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC11685497/
Abstract

CD73, an ectoenzyme responsible for adenosine production, is often elevated in immuno-suppressive tumor environments. Inhibition of CD73 activity holds great promise as a therapeutic strategy for CD73-expressing cancers. In this study, we have developed a therapeutic anti-human CD73 antibody cocktail, HB0045. HB0045 is a 1:1 mixture of two humanized monoclonal IgG1 antibodies (mAbs), HB0038 and HB0039. The cocktail not only harnesses the advantages of its parental mAbs in enzyme inhibition but also shows a significantly greater capability of promoting T cell proliferation in vitro. Structural analyses show that HB0045 effectively locks the CD73 dimer in a "partially open" non-active conformation through a double lock mechanism. In various animal models of syngeneic and xenograft tumors, HB0045 inhibits tumor growth more potently than the single mAbs. Collectively, our findings provide functional and structural insights into the mechanism of a CD73-targeting antibody cocktail.

摘要

CD73是一种负责生成腺苷的胞外酶,在免疫抑制性肿瘤环境中常常上调。抑制CD73活性作为一种针对表达CD73的癌症的治疗策略具有很大的前景。在本研究中,我们开发了一种治疗性抗人CD73抗体鸡尾酒HB0045。HB0045是两种人源化单克隆IgG1抗体(mAb)HB0038和HB0039的1:1混合物。该鸡尾酒不仅利用了其亲本单克隆抗体在酶抑制方面的优势,而且在体外显示出显著更强的促进T细胞增殖的能力。结构分析表明,HB0045通过双锁机制有效地将CD73二聚体锁定在“部分开放”的非活性构象中。在同基因和异种移植肿瘤的各种动物模型中,HB0045比单克隆抗体更有效地抑制肿瘤生长。总体而言,我们的研究结果为靶向CD73的抗体鸡尾酒的作用机制提供了功能和结构方面的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/6b516d76d979/41467_2024_55207_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/3199cb0cce1b/41467_2024_55207_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/1d9a0aae969c/41467_2024_55207_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/26ba69a3de89/41467_2024_55207_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/cf06564827d6/41467_2024_55207_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/6a29dd846ed8/41467_2024_55207_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/6b516d76d979/41467_2024_55207_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/3199cb0cce1b/41467_2024_55207_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/1d9a0aae969c/41467_2024_55207_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/26ba69a3de89/41467_2024_55207_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/cf06564827d6/41467_2024_55207_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/6a29dd846ed8/41467_2024_55207_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3341/11685497/6b516d76d979/41467_2024_55207_Fig6_HTML.jpg

相似文献

1
An antibody cocktail targeting two different CD73 epitopes enhances enzyme inhibition and tumor control.一种靶向两种不同CD73表位的抗体鸡尾酒可增强酶抑制作用并控制肿瘤。
Nat Commun. 2024 Dec 30;15(1):10872. doi: 10.1038/s41467-024-55207-9.
2
Dual Mechanisms of Novel CD73-Targeted Antibody and Antibody-Drug Conjugate in Inhibiting Lung Tumor Growth and Promoting Antitumor Immune-Effector Function.新型 CD73 靶向抗体和抗体药物偶联物抑制肺肿瘤生长和促进抗肿瘤免疫效应功能的双重机制。
Mol Cancer Ther. 2020 Nov;19(11):2340-2352. doi: 10.1158/1535-7163.MCT-20-0076. Epub 2020 Sep 17.
3
Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches.通过蛋白相关化学开关生成肿瘤选择性条件激活生物抗 CTLA4 抗体。
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9). doi: 10.1073/pnas.2020606118.
4
A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms.一种高效能的 CD73 双价抗体通过双重机制阻断酶活性位点的形成。
J Biol Chem. 2020 Dec 25;295(52):18379-18389. doi: 10.1074/jbc.RA120.012395. Epub 2020 Oct 29.
5
Novel anti-CD73-IL-2v bispecific fusion protein augments antitumor immunity by alleviating immunosuppressive adenosine pathways in CD8 T cells.新型抗CD73-IL-2v双特异性融合蛋白通过减轻CD8 T细胞中的免疫抑制腺苷途径增强抗肿瘤免疫力。
J Immunother Cancer. 2025 Mar 13;13(3):e008594. doi: 10.1136/jitc-2023-008594.
6
CD73 blockade enhances the local and abscopal effects of radiotherapy in a murine rectal cancer model.CD73 阻断增强了小鼠直肠癌模型中的局部和远隔放疗效应。
BMC Cancer. 2020 May 12;20(1):411. doi: 10.1186/s12885-020-06893-3.
7
Anti-human CD73 monoclonal antibody inhibits metastasis formation in human breast cancer by inducing clustering and internalization of CD73 expressed on the surface of cancer cells.抗人 CD73 单克隆抗体通过诱导癌细胞表面表达的 CD73 聚集和内化,抑制人乳腺癌的转移形成。
J Immunol. 2013 Oct 15;191(8):4165-73. doi: 10.4049/jimmunol.1301274. Epub 2013 Sep 16.
8
CD73: a novel target for cancer immunotherapy.CD73:癌症免疫治疗的新靶点。
Cancer Res. 2010 Aug 15;70(16):6407-11. doi: 10.1158/0008-5472.CAN-10-1544. Epub 2010 Aug 3.
9
Targeting CD73 enhances the antitumor activity of anti-PD-1 and anti-CTLA-4 mAbs.靶向 CD73 增强了抗 PD-1 和抗 CTLA-4 mAbs 的抗肿瘤活性。
Clin Cancer Res. 2013 Oct 15;19(20):5626-35. doi: 10.1158/1078-0432.CCR-13-0545. Epub 2013 Aug 27.
10
CD73-adenosine: a next-generation target in immuno-oncology.CD73-腺苷:免疫肿瘤学的新一代靶点
Immunotherapy. 2016 Feb;8(2):145-63. doi: 10.2217/imt.15.106. Epub 2016 Jan 25.

引用本文的文献

1
Exploring Multi-Target Therapeutic Strategies for Glioblastoma via Endogenous Network Modeling.通过内源性网络建模探索胶质母细胞瘤的多靶点治疗策略
Int J Mol Sci. 2025 Apr 1;26(7):3283. doi: 10.3390/ijms26073283.

本文引用的文献

1
Tumor intrinsic and extrinsic functions of CD73 and the adenosine pathway in lung cancer.CD73 的肿瘤内在和外在功能以及肺癌中的腺苷通路。
Front Immunol. 2023 Mar 24;14:1130358. doi: 10.3389/fimmu.2023.1130358. eCollection 2023.
2
First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid tumors.在晚期实体瘤患者中单独或联合度伐鲁单抗使用强效、选择性抗 CD73 单克隆抗体 oleclumab 的首次人体研究。
Cancer Immunol Immunother. 2023 Jul;72(7):2443-2458. doi: 10.1007/s00262-023-03430-6. Epub 2023 Apr 5.
3
CD39/CD73/A2AR pathway and cancer immunotherapy.
CD39/CD73/A2AR 通路与癌症免疫治疗。
Mol Cancer. 2023 Mar 2;22(1):44. doi: 10.1186/s12943-023-01733-x.
4
Anti-CD73 antibody activates human B cells, enhances humoral responses and induces redistribution of B cells in patients with cancer.抗 CD73 抗体激活人 B 细胞,增强体液免疫应答,并诱导癌症患者 B 细胞重新分布。
J Immunother Cancer. 2022 Dec;10(12). doi: 10.1136/jitc-2022-005802.
5
Pharmacology, pharmacokinetics, and toxicity characterization of a novel anti-CD73 therapeutic antibody IBI325 for cancer immunotherapy.用于癌症免疫治疗的新型抗CD73治疗性抗体IBI325的药理学、药代动力学及毒性特征
Int J Biol Macromol. 2023 Feb 28;229:158-167. doi: 10.1016/j.ijbiomac.2022.12.258. Epub 2022 Dec 29.
6
Targeting two distinct epitopes on human CD73 with a bispecific antibody improves anticancer activity.双特异性抗体靶向人 CD73 上的两个不同表位可提高抗癌活性。
J Immunother Cancer. 2022 Sep;10(9). doi: 10.1136/jitc-2022-004554.
7
A Novel Anti-CD73 Antibody That Selectively Inhibits Membrane CD73 Shows Antitumor Activity and Induces Tumor Immune Escape.一种选择性抑制膜CD73的新型抗CD73抗体具有抗肿瘤活性并诱导肿瘤免疫逃逸。
Biomedicines. 2022 Mar 31;10(4):825. doi: 10.3390/biomedicines10040825.
8
Anti-PD-L1 and anti-CD73 combination therapy promotes T cell response to EGFR-mutated NSCLC.抗 PD-L1 和抗 CD73 联合治疗可增强 T 细胞对 EGFR 突变型 NSCLC 的反应。
JCI Insight. 2022 Feb 8;7(3):e142843. doi: 10.1172/jci.insight.142843.
9
A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities.一种新型双特异性抗体,靶向 PD-L1 和 VEGF,具有联合抗肿瘤活性。
Front Immunol. 2021 Dec 2;12:778978. doi: 10.3389/fimmu.2021.778978. eCollection 2021.
10
Ordered assembly of the cytosolic RNA-sensing MDA5-MAVS signaling complex via binding to unanchored K63-linked poly-ubiquitin chains.通过与非锚定的 K63 连接的多聚泛素链结合,有序组装细胞质 RNA 感应 MDA5-MAVS 信号复合物。
Immunity. 2021 Oct 12;54(10):2218-2230.e5. doi: 10.1016/j.immuni.2021.09.008.